Highlighting controversial clinical news among HCPs

Steve Smith, PA, VP Global Content Strategy, Aptus Health 

Of the thousands of new pieces of clinical content that are released by reputable sources every weekday, only about 2% include information that the practicing healthcare professional (HCP) needs to know. Univadis aims to help HCPs cut through the clutter to focus on the clinically essential content that’s most relevant for them– that vital two percent.  

Our “Practice Changers” feature relies on physician experts to help us tighten our focus even more and identify the tiny percentage of new content that has the potential to actually change practice. We then invite our members to share their assessment of the newsworthy item by asking them whether or not it really has the potential to change how they practice.

Most recently, we presented HCP members of Univadis with two potentially practice-changing statements; one related to treating minor stroke/transient ischemic attack (TIA) and one related to a therapy’s ability to improve outcomes with type 2 diabetes in patients with or without cardiovascular disease. The platform invited HCPs to learn more about the recent clinical news, with content presented in an easy-to-digest format that’s unique to Univadis.

Here’s what their responses tell us:

The approach to TIA and minor stroke may be changing: 71% of physicians agreed that the minor stroke article should change how doctors practice.


A statement about treating diabetes patients proved to be more controversial; just 57% of HCPs agree with this statement, suggesting that in the SGLT-2i space, there is some conservative thinking and belief that older drugs with fewer potential adverse effects can achieve similar results. 


These are just a few examples of how HCPs engage in content on Univadis, sharing their attitudes and beliefs about clinical news and updates that impact their practice. 

Are you part of the conversation?

  1. ← Previous
  2. Next →